Additional triggers of endothelial dysfunction modulate antiphospholipid-mediated microangiopathy in a central nervous system-cutaneous syndrome

Julius Birnbaum

Research output: Contribution to journalArticlepeer-review

Abstract

It is now recognised that the spectrum of antiphospholipid (aPL)-mediated syndromes includes end-organ injury due to microangiopathic manifestations. In the central nervous system (CNS), the clinical and radiographic appearance of microangiopathic lesions can be notoriously difficult to distinguish from multiple sclerosis (MS). A patient is presented who developed white-matter lesions in the brain and spinal-cord, shortly after receiving toxic doses of radiation for an arterio-venous malformation. The institution of interferon therapy for presumptive MS not only led to worsening neurologic deficits, but triggered a cutaneous syndrome with pleomorphic stigmata of microvascular injury (livedo reticularis rash, splinter haemorrhages). Subsequent workup revealed persistently elevated high-titer antiphospholipid of multiple isotypes. Treatment with corticosteroids and immunosuppressant therapy afforded improvement in locomotor function. We hypothesise that radiation injury and treatment with interferon-therapy constituted iatrogenic "hits" of endothelial injury, and potentiated aPL-mediated microangiopathic disease affecting the CNS and the skin.

Original languageEnglish (US)
Pages (from-to)411-415
Number of pages5
JournalClinical and experimental rheumatology
Volume28
Issue number3
StatePublished - Dec 1 2010

Keywords

  • Antiphospholipid antibody syndrome
  • Neuropsychiatric disease

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Additional triggers of endothelial dysfunction modulate antiphospholipid-mediated microangiopathy in a central nervous system-cutaneous syndrome'. Together they form a unique fingerprint.

Cite this